1206482-78-1

Basic information

• Product Name: 2-(4-{[(3-chlorophenyl)amino]carbonothioyl}-1-piperazinyl)-8-ethyl-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylic acid
• Synonyms: 2-(4-{[(3-chlorophenyl)amino]carbonothioyl}-1-piperazinyl)-8-ethyl-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylic acid
• CAS NO: 1206482-78-1
• Molecular Weight: 472.955
• Mol File: 1206482-78-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2-(4-{[(3-chlorophenyl)amino]carbonothioyl}-1-piperazinyl)-8-ethyl-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-{[(3-chlorophenyl)amino]carbonothioyl}-1-piperazinyl)-8-ethyl-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylic acid(1206482-78-1)
• EPA Substance Registry System: 2-(4-{[(3-chlorophenyl)amino]carbonothioyl}-1-piperazinyl)-8-ethyl-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylic acid(1206482-78-1)

Safety Data

• Hazardous Substances Data: 1206482-78-1(Hazardous Substances Data)

Upstream product

• 51940-44-4 pipedimic acid 
• 2392-68-9 3-chlorophenyl-isothiocyanate 

Relevant articles and documents

Identification of a potent small-molecule inhibitor of bacterial DNA repair that potentiates quinolone antibiotic activity in methicillin-resistant Staphylococcus aureus

The global emergence of antibiotic resistance is one of the most serious challenges facing modern medicine. There is an urgent need for validation of new drug targets and the development of small molecules with novel mechanisms of action. We therefore sou

PIPEMIDIC ACID DERIVATIVE AUTOTAXIN INHIBITORS

Novel and optimized classes of pipemidic acid derivative compounds that exhibit effective inhibition of autotaxin enzymes are provided. Such classes of compounds exhibit exhibit reactivity with autotaxin to ultimately reduce the size of the reactive sites thereon to prevent conversion of lysophosphatidyl choline to lysophophatidic acid. Furthermore, such compounds can be incorporated within delivery forms for human ingestion. As such, these compounds accord an excellent manner of potentially reducing generation of certain cancers attributable to the presence of naturally occurring autotaxin within the human body. Methods of inactivating autotaxin to certain degrees therewith such compounds are encompassed within invention as well.